ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
사전등록 바로가기
 

  • P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

논문 상세

Home > 논문 상세
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

논문 상세

    이전

    다음

    35권 2호
    PubReader Citation Share

    Development and validation of an analytical method to quantify baphicacanthin A by LC-MS/MS and its application to pharmacokinetic studies in mice

    분석과학 / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2022, v.35 no.2, pp.60-68
    https://doi.org/10.5806/AST.2022.35.2.60
    So Yeon Jeon (College of Pharmacy, Dankook University)
    San Kim (College of Pharmacy, Dankook University)
    Jin-Hyang Park (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University)
    Im-Sook Song (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University)
    Young Taek Han (College of Pharmacy, Dankook University)
    Min-Koo Choi (College of Pharmacy, Dankook University)
    So, Y. J. , San, K. , Jin-Hyang, P. , Im-Sook, S. , Young, T. H. , & Min-Koo, C. (2022). . 분석과학, 35(2), 60-68, https://doi.org/10.5806/AST.2022.35.2.60
    • 다운로드 수
    • 조회수

    Abstract

    In this study, we developed and validated a sensitive analytical method to quantify baphicacanthin A in mouse plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The standard calibration curves for baphicacanthin A ranged from 0.5 to 200 ng/mL and were linear, with an r2 of 0.985. The inter- and intra-day accuracy and precision and the stability fell within the acceptance criteria. Besides, we investigated the pharmacokinetics of baphicacanthin A following its intravenous (5 mg/kg) and oral administration (30 mg/kg). Intravenously injected baphicacanthin A showed biphasic elimination kinetics with high clearance and volume of distribution values. Furthermore, baphicacanthin A showed a rapid absorption but low aqueous solubility (182.51±0.20 mg/mL), resulting in low plasma concentrations and low oral bioavailability (2.49%). Thus, we successfully documented the pharmacokinetic properties of baphicacanthin A using this newly developed sensitive LC-MS/MS quantification method, which could be used in future lead optimization and biopharmaceutic studies.

    keywords
    baphicacanthin A, analytical method validation, LC-MS/MS, bioavailability


    참고문헌

    1

    1. M. Le Roes-Hill, C. Goodwin and S. Burton, Trends in Biotechnology, 27(4), 248-258 (2009).

    2

    2. C. Eggert, U. Temp, J. F. Dean and K. E. Eriksson, FEBS Letters, 376(3), 202-206 (1995).

    3

    3. A. Bolognese, G. Correale, M. Manfra, A. Lavecchia, O. Mazzoni, E. Novellino, V. Barone, A. Pani, E. Tramontano, P. La Colla, C. Murgioni, I. Serra, G. Setzu and R. Loddo, Journal of Medicinal Chemistry, 45(24), 5205-5216(2002).

    4

    4. N. Lohani, H. N. Singh, and R. R. Moganty, International Journal of Biological Macromolecules, 87, 433-442(2016).

    5

    5. S. Katsamakas, A. L. Zografos and V. Sarli, Current Medicinal Chemistry, 23(26), 2972-2999 (2016).

    6

    6. S. Ahn, J. A. Yoon and Y. T. Han, Bulletin of the Korean Chemical Society, 40(7), 740-742 (2019).

    7

    7. Q.-T. Feng, G.-Y. Zhu, W.-N. Gao, Z. Yang, N. Zhong, J.-R. Wang and Z.-H. Jiang, Chemical and Pharmaceutical Bulletin, 64(10), 1505-1508 (2016).

    8

    8. T. Tanaka, T. Ikeda, M. Kaku, X. H. Zhu, M. Okawa, K. Yokomizo, M. Uyeda and T. Nohara, Chemical and Pharmaceutical Bulletin, 52(10), 1242-1245 (2004).

    9

    9. B. Zhou, Z. Yang, Q. Feng, X. Liang, J. Li, M. Zanin, Z. Jiang and N. Zhong, Journal of Ethnopharmacology, 199, 60-67 (2017).

    10

    10. Y. Cuan, W. Li, Y. Dou and G. Yang, Natural Product Research, in press (2021), DOI: 10.1080/14786419.2021. 2011275.

    11

    11. K. B. Adhikari, H. N. Lærke, A. G. Mortensen and I. S. Fomsgaard, Journal of Agricultural and Food Chemistry, 60(46), 11518-11524 (2012).

    12

    12. K. B. Adhikari, B. B. Laursen, H. N. Lærke and I. S. Fomsgaard, Journal of Agricultural and Food Chemistry, 60(10), 2497-2506 (2012).

    13

    13. S. K. Steffensen, H. A. Pedersen, K. B. Adhikari, B. B. Laursen, C. Jensen, S. Høyer, M. Borre, H. H. Pedersen, M. Borre, D. Edwards and I. S. Fomsgaard, Journal of Agricultural and Food Chemistry, 64(43), 8235-8245(2016).

    14

    14. M. K. Choi, S. J. Nam, H. Y. Ji, M. J. Park, J. S. Choi and I. S. Song, Pharmaceutics, 12(3), 268 (2020).

    15

    15. J. H. Jeon, J. Lee, M. K. Choi and I. S. Song, Archives of Pharmacal Research, 43(12), 1335-1346 (2020).

    16

    16. J. H. Jeon, J. Lee, J. H. Park, C. H. Lee, M. K. Choi and I. S. Song, Pharmaceutics, 13(9), 1496 (2021).

    17

    17. J. H. Jeon, J. Lee, C. H. Lee, M. K. Choi and I. S. Song, Mass Spectrometry Letters, 12(1), 16-20 (2021).

    18

    18. M. Pang, J. Lee, J. H. Jeon, I. S. Song, Y. T. Han and M. K. Choi, Mass Spectrometry Letters, 12(4), 200-205(2021).

    19

    19. S. Chandran and R. S. Singh, Die Pharmazie, 62(1), 4-14 (2007).

    20

    20. L. Tanner, J. C. Evans, R. Seldon, A. Jordaan, D. F. Warner, R. K. Haynes, C. J. Parkinson and L. Wiesner, Antimicrobial Agents and Chemotherapy, 63(11), e01010-19 (2019).

    21

    21. K. B. Adhikari, B. B. Laursen, P. L. Gregersen, H. J. Schnoor, M. Witten, L. K. Poulsen, B. M. Jensen and I. S. Fomsgaard, Molecular Nutrition & Food Research, 57(10), 1847-1858 (2013).

    22

    22. B. M. Jensen, K. B. Adhikari, H. J. Schnoor, N. Juel-Berg, I. S. Fomsgaard and L. K. Poulsen, European Journal of Nutrition, 56(1), 387-397 (2017).

    • 다운로드 수
    • 조회수
    • 0KCI 피인용수
    • 0WOS 피인용수

    권호 내 다른 논문

    추천 논문

    상단으로 이동

    권호 목록

    소개

    규정 및 지침

    게시판

    COPYRIGHT ⓒ - 한국분석과학회
    서울 마포구 마포대로 127;풍림VIP텔 1603호;(공덕동), +82-(0)2-701-8662
    proton@jbnu.ac.kr

      학술지 홈페이지 이용 환경은   크롬 브라우저 사용을 권장합니다.

    분석과학

    논문 투고 OA 정책